This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Medifirst Solutions, Inc. Welcomes Physician To Advisory Board

Stocks in this article: MFST

BOCA RATON, Fla., April 3, 2013 /PRNewswire/ -- MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like to welcome Kenneth R. Pearlberg MD FACS to the Medifirst Solutions Advisory Board. Says CEO Bruce J. Schoengood, "We are honored to have an accomplished physician of his caliber contribute to the Advisory Board.  Dr. Pearlberg brings a wealth of experience and medical expertise to Medifirst and everybody involved with the company is excited to have him on board."  His diverse and distinguished career includes: Ophthalmic Surgeon,  On-Air TV Consultant, Innovator and Professional Speaker.  Dr. Pearlberg has been honored by Harvard Medical School and is a graduate of SUNY-Downstate Medical School. Continues Schoengood, "I am very pleased as to the progress of putting together a first-rate Advisory Board consisting of accomplished medical professionals that will help contribute to developing and executing the company  strategy to bring and develop new products and solutions to the medical industry."

Dr. Pearlberg's accomplishments and background include:Medical Consultant: (On-Air) – Fox 25 NewsSurgeon Director: Lima Eye SurgeryCEO: Eye Surgery, Inc.Medical Consultant: Tissue Engineering Refraction, Inc.Speaker: Alcon  Pharmaceuticals, Allergan and Bausch & LombDirector of Ocular Surgery and Chief of Ophthalmology:America's Health Choice Medical Plans, Inc.Medical Resources, LLCMedical Specialists: Senior PhysicianChen Medical Centers: Director of Ophthalmology

Medifirst Solutions continues to make significant progress in establishing business and strategic relationships with industry-leading and innovative organizations. The company goal is to create a diverse portfolio of technology and assets, with a focus on innovative products, while producing revenue and growth within the medical, health and mental health sectors. The company is confident that it will continue to make substantial progress towards achieving our business goals in the coming weeks and months.

About Medifirst Solutions, Inc.

Medifirst Solutions, Inc. is a Nevada corporation that is based in Florida and New Jersey. The company seeks innovative medical and healthcare products and technologies which are targeted to both medical and healthcare professionals and everyday consumers. Medifirst Solutions is developing and establishing both consumer and professional medical and cliental to be used as a pipeline that will allow for distribution of our new products and services. Visit www.medifirstsolutions.com for more information.

Forward-Looking Statements:  The statements in this press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control.  Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission.  Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.  We make no commitment to disclose any subsequent revisions to forward-looking statements.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs